MRI Evaluation of the Liver

Kimberly L. Beavers; Richard C. Semelka

doi:10.1055/s-2001-15343

Seminars in Liver Disease, Table of Contents

Semin Liver Dis 2001; 21(2): 161-178
DOI: 10.1055/s-2001-15343

MRI Evaluation of the Liver

Kimberly L. Beavers¹ , Richard C. Semelka²

¹Department of Medicine, Division of Digestive Diseases, University of North Carolina, School of Medicine, Chapel Hill, North Carolina
²Department of Radiology, University of North Carolina, School of Medicine, Chapel Hill, North Carolina

Abstract

ABSTRACT

Following the introduction of rapid, high-quality scan techniques and the development of new, tissue-specific contrast agents, the applications of magnetic resonance imaging (MRI) for liver imaging continue to grow. MRI using a T1-weighted sequence, T2-weighted sequence, and serial gadolinium-enhanced gradient echo sequences is very effective at both detecting and characterizing various hepatic lesions. The use of a growing number of contrast agents has the potential to increase the sensitivity and specificity of liver MRI in numerous pathological conditions by improving morphological and functional information. This article examines the current status of liver MRI, highlighting technical and methodological approaches, contrast agents, and main clinical applications. MRI appears to be an ideal diagnostic tool for the detection and characterization of liver disease.

KEYWORD

Contrast agents - diagnosis - liver - magnetic resonance imaging

Full Text

References

REFERENCES

1 Hamm B, Thoeni R F, Gould R G. Focal liver lesions: characterization with nonenhanced and dynamic contrast material-enhanced MR imaging. Radiology . 1994; 190 417-423
2 Semelka R C, Worawattanakul S, Kelekis N L. Liver lesions detection, characterization, and effect on patient management: comparison of single-phase spiral CT and current MR techniques. J Magn Reson Imag . 1997; 7 1040-1047
3 Semelka R C, Helmberger T K. Contrast agents for MR imaging of the liver. Radiology . 2000; 218 27-38
4 Semelka R C, Balci N C, Op de Beeck B, Reinhold C. Evaluation of a 10-minute comprehensive MR imaging examination of the upper abdomen. Radiology . 1999; 211 189-195
5 Semelka R C, Willms A B, Brown M A. Comparison of breath-hold T1-weighted MR sequences for imaging of the liver. JMRI . 1994; 4 759-765
6 Rofsky N M, Lee V S, Laub G. Abdominal MR imaging with a volumetric interpolated breath-hold examination. Radiology . 1999; 212 876-884
7 Lee V S, Lavelle M T, Rofsky N M. Hepatic MR imaging with a dynamic contrast-enhanced isotropic volumetric interpolated breath-hold examination: feasibility, reproducibility, and technical quality. Radiology . 2000; 215 365-371
8 Rofsky N M, Lee V S, Laub G. Abdominal MR imaging with a volumetric interpolated breath-hold examination. Radiology . 2000; 212 876-884
9 Semelka R C, Kelekis N L. Liver. In: Semelka RC, Ascher SM, Reinhold C, eds. MRI of the Abdomen and Pelvis: A Text-Atlas New York: Wiley-Liss 1997: 19-135
10 Kelekis N L, Semelka R C, Woosley J T. Malignant lesions of the liver with high signal intensity on T1-weighted MR images. J Magn Reson Imag . 1996; 6 291-294
11 Low R N, Francis I R, Sigeti J S, Foo T K. Abdominal MR imaging: comparison of T2-weighted fast conventional spin-echo, and contrast-enhanced fast multiplanar spoiled gradient-recalled imaging. Radiology . 1993; 186 803-811
12 Semelka R C, Cumming M J, Shoenut J P. Islet cell tumors: comparison of dynamic contrast-enhanced CT and MR imaging with dynamic gadolinium enhancement and fat suppression. Radiology . 1993; 186 799-802
13 Larson R E, Semelka R C, Bagley A S. Hypervascular malignant liver lesions; comparison of various MR imaging pulse sequences and dynamic CT. Radiology . 1994; 192 393-399
14 Low R N, Semelka R C, Worawattanakul S. Extra hepatic abdominal imaging in patients with malignancy: comparison of MR imaging and helical CT with subsequent surgical correlation. Radiology . 1999; 210 625-632
15 Oi H, Murakami T, Kim T. Dynamic MR imaging and early-phase helical CT for detection small intrahepatic metastases of hepatocellular carcinoma. AJR . 1996; 366 369-374
16 Yamashita Y, Mitsuzaki K, Yi T. Small hepatocellular carcinoma in patients with chronic liver damage: prospective comparison of detection with dynamic MR imaging and helical CT of the whole liver. Radiology . 1996; 200 79-84
17 Semelka R C, Shoenut J P, Ascher S M. Solitary hepatic metastasis: comparison of dynamic contrast-enhanced CT and MR imaging with fat-suppressed T2-weighted, breath-hold T1-weighted FLASH, and dynamic gadolinium-enhanced FLASH sequences. J Magn Imag . 1994; 4 319-323
18 Whitney W S, Herfkens R J, Jeffrey R B. Dynamic breath-hold multiplanar spoiled gradient-recalled MR imaging with gadolinium enhancement for differentiating hepatic hemangiomas from malignancies at 1.5T. Radiology . 1993; 189 863-870
19 Mahfouz A D, Hamm B, Taupitz M, Wold K J. Hypervascular liver lesions: differentiation of focal nodular hyperplasia from malignant tumors with dynamic gadolinium-enhanced MR imaging. Radiology . 1993; 186 133-138
20 Peterson M A, Baron R L, Murakami T. Hepatic malignancies: usefulness of acquisition of multiple arterial and portal venous phase images at dynamic gadolinium-enhanced MR imaging. Radiology . 1996; 201 337-345
21 Whitney W S, Herfkens R J, Jeffrey R B. Dynamic breath-hold multiplanar spoiled gradient-recalled MR imagining with gadolinium enhancement for differentiating hepatic hemangiomas from malignancies at 1.5 T. Radiology . 1993; 189 863-870
22 Yamashita Y, Fan Z M, Yamamoto H. Spin-echo and dynamic gadolinium-enhanced FLASH MR imaging of hepatocellular carcinoma: correlation with histopathologic findings. J Magn Reson Imaging . 1994; 4 83-90
23 Yoshida H, Itai Y, Ohtomo K. Small hepatocellular carcinoma and cavernous hemangioma; differentiation with dynamic FLASH MR imaging with Gd-DTPA. Radiology . 1989; 171 339-342
24 Kelekis N L, Semelka R C, Siegelman E S. Focal hepatic lymphoma: magnetic resonance demonstration using current techniques including gadolinium enhancement. Magn Reson Imaging . 1997; 15 625-636
25 Balci N C, Semelka R C, Noone T C. Pyogenic hepatic abscesses: MRI findings on T1- and T2-weighted serial gadolinium-enhanced gradient-echo image. J Magn Reson Imaging . 1999; 9 285-290
26 Semelka R C, Brown E D, Ascher S M. Hepatic hemangiomas: a multi-institutional study of appearance of T2-weighted and serial gadolinium-enhanced gradient-echo MR images. Radiology . 1994; 192 401-406
27 Semelka R C, Hussain S M, Marcos H B, Woosley J T. Perilesional enhancement of hepatic metastases: correlation between MR imaging and histopathologic findingsinitial observations. Radiology . 2000; 215 89-94
28 Eisenberg L B, Lee J KT. Transient increased segmental hepatic enhancement distal to portal vein obstruction on dynamic gadolinium-enhanced gradient echo MR images. J Magn Reson Imaging . 1995; 4 375-377
29 Schlund J F, Semelka R C, Kettritz U. Correlation of perfusion abnormalities on CTAP and immediate postintravenous gadolinium-enhanced gradient echo MRI. Abdom Imaging . 1996; 21 49-52
30 Noone T C, Semelka R C, Woosley J T, Pisano E D. Ultrasound and MR findings in acute Budd-Chiari syndrome with histopathologic correlation. J Comput Assist Tomgr . 1996; 20 819-822
31 Noone T, Semelka R C, Siegelman E. Budd Chiari syndrome: spectrum of appearances of acute, subacute, and chronic disease with magnetic resonance imaging. J Magn Reson Imaging . 2000; 11 44-50
32 Giovagnoni A, Paci E, Terilli F. Quantative MR imaging data in the evaluation of hepatic metastases during systemic chemotherapy. J Magn Reson Imaging . 1995; 5 27-32
33 Worawattanakul S, Semelka R C, Kelekis N L, Woosley J T. Angiosarcoma of the liver: MR imaging pre- and post-chemotherapy. Magn Reson Imaging . 1997; 15 613-617
34 Semelka R C, Kelekis N, Burdeny D, Lee J KT. Chemotherapy-treated liver metastases mimicking hemangiomas on MR images. Abdom Imaging . 1999; 24 378-382
35 Mathie D, Rahmouni A, Anglade M C. Focal nodular hyperplasia of the liver: assessment with contrast-enhanced Turbo-FLASH MR imaging. Radiology . 1991; 180 25-30
36 Mahfouz A E, Hamm B, Wolf K J. Peripheral washout: a sign of malignancy on dynamic gadolinium-enhanced MR images of focal liver lesions. Radiology . 1994; 190 49-52
37 Low R N, Sigeti J S, Francis I R. Evaluation of malignant biliary obstruction: efficacy of fast multiplanar spoiled gradient-recalled MR imaging versus spin-echo MR imaging, CT and cholangiography. AJR . 1994; 162 315-323
38 Low R N, Sigeti J S. MR imaging of peritoneal disease: comparison of contrast enhanced fast multiplanar spoiled gradient-recalled and spin-echo imaging. AJR . 1994; 162 1131-1136
39 Worawattanakul S, Semelka R C, Noone R C. Cholangiocarcinoma: spectrum of appearances on MR images using current techniques. Magn Reson Imaging . 1998; 16 993-1003
40 Seneterre E, Tauourel P, Bouvier Y. Detection of hepatic metastases: ferumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography. Radiology . 1996; 200 785-792
41 Ward J, Niak K S, Gurthrie J A. Hepatic lesion detection: comparison of MR imaging after the administration of superparamagnetic iron oxide with dual-phase CT by using alternative-free response receiver operating characteristic analysis. Radiology . 1999; 210 459-466
42 Ros P R, Freeny P C, Harms S E. Hepatic MR imaging with ferumoxides: a multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions. Radiology . 1995; 196 481-488
43 Oudkert M, van den Heuvel G A, Wielopolski P A. Hepatic lesions: detection with ferumoxide-enhanced T1-weighted MR imaging. Radiology . 1997; 203 449-456
44 Blakeborough A, Ward J, Wilson D. Hepatic lesion detection at MR imaging: a comparative study with four sequences. Radiology . 1997; 203 759-765
45 Shamsi K, Blazer T, Saini S. Superparamagnetic iron oxide particles (SHU 555 A): evaluation of efficacy in three doses for hepatic MR imaging. Radiology . 1998; 206 365-371
46 Mergo P, Helmberger T, Nicolas A. Ring enhancement in ultrasmall superparamagnetic iron oxide MR imaging: a potential new sign for characterization of liver lesions. AJR . 1996; 166 379-384
47 Kopp A F, Laniado M, Dammann F. MR imaging of the liver with Resovist: safety, efficacy, and pharmacodynamic properties. Radiology . 1997; 204 749-756
48 Vogl T J, Hammerstingl R, Schwarz W. Magnetic resonance imaging of focal liver lesions: comparison of the superparamagentic iron oxide Resovist versus gadolinium-DTPA in the same patient. Invest Radiol . 1996; 31 696-708
49 Hammerstingl R, Vogl T J, Schwarz W. Contrast-enhanced MRI of focal liver lesions: differentiation and detection of primary and secondary liver lesions using Resovist-enhanced versus gadolinium-enhanced MRI in the same patient. Acta Radiol . 1998; 5 75-79
50 Reimer P, Rummeny E J, Daldrup H E. Clinical results with Resovist: a phase 2 clinical trial. Radiology . 1995; 195 489-496
51 Liou J, Lee J K, Borrello J A, Brown J J. Differentiation of hepatomas from nonhepatomatous masses: use of MnDPDP-enhanced MR images. Magn Reson Imaging . 1994; 12 71-79
52 Wang C, Ahlstrom H, Ekholm S. Diagnostic efficiency of Mn-DPDP in MR imaging of the liver: a phase III multicenter study. Acta Radiol . 1997; 38 643-649
53 Mitchell D G, Alam F. Mangafodipir trisodium: effects on T2-and T1-weighted MR cholangiography. J Magn Reson Imaging . 1999; 9 366-368
54 Caudann R, Morana G, Pirovano G P. Focal malignant liver lesions: MR imaging enhanced with gadolinium benzoxypropionictetra-acetate (BOPTA)preliminary results of phase II clinical application. Radiology . 1996; 199 513-520
55 Hamm B, Staks T, Muhler A. Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. Radiology . 1995; 195 785-792
56 Vogl T J, Jummel S, Hammerstingl R. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA. Radiology . 1996; 200 59-67
57 Vassiliades V G, Foley W D, Alarcon J. Hepatic metastases CT versus MR imaging at 1.5T. Gastrointest Radiol . 1991; 16 159-163
58 Semelka R C, Schlund J F, Molina P L. Malignant liver lesions: comparison of spiral CT arterial portography and MR imaging for diagnostic accuracy, cost, and effect on patient management. J Magn Reson Imaging . 1996; 1 39-43
59 Hagspiel K D, Neidl K F, Eichenberger A C. Detection of liver metastases: comparison of superparamagnetic iron oxide-enhanced and unenhanced MR imaging at 1.5T with dynamic CT, intraoperative US, and percutaneous US. Radiology . 1995; 196 471-478
60 Kettritz U, Schlund J F, Wilbur K. Comparison of gadolinium with manganese-DPDP for liver lesion detection and characterization: preliminary results. Magn Reson Imaging . 1996; 14 1185-1190
61 Vogl T J, Hammerstingl R, Schwarz W. Superparamagnetic iron oxide-enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesions. Radiology . 1996; 198 881-887
62 Rofsky N M, Weinreb J C, Bosniak M A. Renal lesion characterization with gadolinium-enhanced MR imaging: efficacy and safety in patients with renal insufficiency. Radiology . 1991; 180 85-89
63 Low R N, Carter W D, Saleh F, Sigeti J S. Ovarian cancer: comparison of findings with perfluorocarbon-enhanced MR imaging, In-111-SYT-103 immunoscintigraphy, and CT. Radiology . 1995; 195 391-400
64 Semelka R C, Shoenut J P, Magro C M. Renal cancer staging: comparison of contrast-enhanced CT and gadolinium-enhanced fat-suppressed spin-echo and gradient-echo MR imaging. J Magn Reson Imaging . 1993; 3 597-602
65 McFarland E F, May Smith W W, Saini S. Hepatic hemangiomas and malignant tumors: improved differentiation with heavily T2W spin-echo MR imaging. Radiology . 1994; 193 43-47
66 Elizondo G, Weissleder R, Stark D D. Amebic liver abscess: diagnosis and treatment of evaluation with MR imaging. Radiology . 1992; 185 1-11
67 Marti-Bonmati L, Lonjedo E, Poyados C, Casillas C. Mn-DPDP enhancement characteristics and differentiation between cirrhotic and noncirrhotic livers. Invest Radiol . 1998; 33 717-722
68 Bachmann R, Kreft B, Dombrowski F. Enhanced tumor detection in the presence of liver cirrhosis: experimental study on the diagnostic value of a superparamagnetic iron oxide MR imaging contrast agent. J Magn Reson Imaging . 1999; 9 251-256
69 Kanematsu M, Hoshi H, Yamada T. Small hepatic nodules in cirrhosis: ultrasonographic, CT, and MR imaging findings. Abdom Imaging . 1999; 24 47-55
70 Kuwatsuru R, Brasch R C, Muhler A. Definition of liver tumors in the presence of diffuse liver disease: comparison of findings at MR imaging with positive and negative contrast agents. Radiology . 1997; 202 131-138
71 Guyader D, Gandon Y, Sapey T. Magnetic resonance iron-free nodules in genetic hemochromatosis. Am J Gastroenterol . 1999; 94 1083-1086
72 Mitchell D G, Saini S, Weinreb J. Hepatic metastases and cavernous hemangiomas: distinction with standard-and triple-dose gadoteridol-enhanced MR imaging. Radiology . 1994; 193 49-57
73 Lencioni R, Donati F, Copmo D. Detection of colorectal liver metastases: prospective comparison of unenhanced and ferumoxides-enhanced magnetic resonance imaging at 1.5 T, dual-phase spiral CT, and spiral CT during arterial portography. MAGMA . 1998; 7 76-87
74 Strotzer M, Fmeinwieser J, Schmidt J. Diagnosis of liver metastases from colorectal carcinoma: comparison of spiral-CTAP combined with intravenous contrast-enhanced spiral CT and SPIO-enhanced MR combined with plain MR imaging. Acta Radiol . 1997; 38 986-992
75 Lencioni R, Mascalchi M, Caramella D, Bartolozzi C. Small hepatocellular carcinoma: differentiation from adenomatous hyperplasia with color Doppler US and dynamic Gd-DTPA-enhanced MR imaging. Abdom Imaging . 1996; 21 41-48
76 Bartolozzi C, Lencioni R, Caramella D. Treatment of hepatocellular carcinoma with percutaneous ethanol injection: evaluation with contrast-enhanced MR imaging. AJR . 1994; 162 827-831
77 Fujita T, Honjo K, Ito K. Dynamic MR follow-up of small hepatocellular carcinoma after percutaneous ethanol injection therapy. J Comput Assist Tomogr . 1998; 22 379-386
78 Sironi S, DeCobelli F, Livraghi T. Small hepatocellular carcinoma treated with percutaneous ethanol injection: unenhanced and gadolinium-enhanced MR imaging follow-up. Radiology . 1994; 192 407-412